NASDAQ : PRFX

PRF Technologies Ltd. — Financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · Israel

Last price 0.7502 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.63M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

PRF Technologies Ltd. (PRFX) reported revenue of 31.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue31.00K17.00K
Cost of Revenue126.00K70.00K
Gross Profit-95.00K-53.00K
Selling, General & Admin2.49M3.17M2.97M3.55M4.45M4.35M
Research & Development1.66M1.14M11.71M6.04M4.42M2.86M
Amortization of Goodwill & Intangibles1.04M759.00K
Operating Expenses5.20M5.07M14.67M9.58M8.87M7.21M
Operating Income-5.29M-5.12M-14.67M-9.58M-8.87M-7.21M
Interest & Investment Income131.00K120.00K101.00K406.00K160.00K
Currency Exchange Gain (Loss)-92.00K-2.00K6.00K2.00K-61.00K-22.00K
Other Non Operating Income (Expenses)-383.00K-10.00K-14.00K-160.00K-13.00K-10.00K
Pretax Income-5.64M-5.01M-14.58M-9.34M-8.78M-7.24M
Income Tax Expense10.00K8.00K8.00K8.00K9.00K6.00K
Earnings From Continuing Operations-5.65M-5.02M-14.59M-9.34M-8.79M-7.25M
Minority Interest in Earnings329.00K184.00K
Net Income-5.32M-4.84M-14.59M-9.34M-8.79M-7.25M
Net Income to Common-5.32M-4.84M-14.59M-9.34M-8.79M-7.25M
Shares Outstanding (Basic)1.06M647.97K138.25K76.00K27.71K
Shares Outstanding (Diluted)1.06M647.97K138.25K76.00K27.71K
EPS (Basic)-5.00-7.47-105.52-122.94-317.29
EPS (Diluted)-5.00-7.47-105.52-122.94-317.29
Free Cash Flow-4.41M-3.96M-12.63M-6.69M-6.46M-6.60M
Free Cash Flow Per Share-4.14-6.11-91.38-87.99-233.31
Operating Margin-17,077.42%-30,129.41%
Profit Margin-17,158.06%-28,458.82%
Free Cash Flow Margin-14,229.03%-23,276.47%
EBITDA-4.24M-4.35M-14.66M-9.57M-8.85M-7.20M
D&A For EBITDA1.06M774.00K16.00K15.00K15.00K7.00K
EBIT-5.29M-5.12M-14.67M-9.58M-8.87M-7.21M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents8.53M3.12M4.26M8.03M4.10M16.54M
Short-Term Investments3.01M1.02M6.08M
Cash & Short-Term Investments11.54M4.14M4.26M8.03M10.18M16.54M
Other Receivables177.00K142.00K119.00K45.00K55.00K218.00K
Receivables177.00K142.00K119.00K45.00K55.00K218.00K
Prepaid Expenses143.00K36.00K38.00K1.72M2.04M2.20M
Restricted Cash27.00K25.00K10.00K10.00K10.00K34.00K
Other Current Assets7.00K30.00K
Total Current Assets11.88M4.35M4.43M9.80M12.28M19.02M
Property, Plant & Equipment73.00K56.00K97.00K131.00K44.00K53.00K
Goodwill186.00K186.00K
Other Intangible Assets6.95M7.41M
Total Assets19.09M12.00M4.53M9.93M12.33M19.07M
Accounts Payable182.00K213.00K296.00K221.00K209.00K136.00K
Accrued Expenses2.11M2.21M2.10M2.13M855.00K621.00K
Current Portion of Leases50.00K21.00K45.00K56.00K
Total Current Liabilities2.34M2.44M2.44M2.41M1.06M757.00K
Long-Term Leases30.00K
Other Long-Term Liabilities271.00K267.00K259.00K251.00K243.00K234.00K
Total Liabilities2.62M2.71M2.70M2.69M1.31M991.00K
Common Stock94.00K94.00K
Additional Paid-In Capital79.96M69.83M58.27M49.10M43.45M41.72M
Retained Earnings-64.09M-61.29M-56.45M-41.86M-32.52M-23.73M
Total Common Equity15.87M8.54M1.82M7.24M11.02M18.08M
Minority Interest602.00K747.00K
Shareholders' Equity16.48M9.29M1.82M7.24M11.02M18.08M
Total Liabilities & Equity19.09M12.00M4.53M9.93M12.33M19.07M
Total Debt50.00K21.00K45.00K86.00K
Net Cash (Debt)11.48M4.12M4.22M7.94M10.18M16.54M
Net Cash Per Share10.796.3630.49104.47367.41
Filing Date Shares Outstanding3.04M844.37K294.28K14.40K
Total Common Shares Outstanding3.04M830.61K294.28K14.40K
Working Capital9.54M1.91M1.99M7.39M11.22M18.26M
Book Value Per Share5.2210.296.20502.60
Tangible Book Value8.74M952.00K1.82M7.24M11.02M18.08M
Tangible Book Value Per Share2.871.156.20502.60

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-5.32M-4.84M-14.59M-9.34M-8.79M-7.25M
Depreciation & Amortization1.06M774.00K16.00K15.00K15.00K7.00K
Stock-Based Compensation89.00K447.00K310.00K804.00K1.73M1.22M
Other Operating Activities37.00K-186.00K-16.00K218.00K-85.00K
Change in Accounts Payable-142.00K-243.00K76.00K12.00K73.00K-585.00K
Change in Other Net Operating Assets-129.00K91.00K1.58M1.62M599.00K47.00K
Operating Cash Flow-4.41M-3.96M-12.62M-6.68M-6.46M-6.55M
Capital Expenditures-4.00K-2.00K-13.00K-9.00K-6.00K-50.00K
Cash Acquisitions20.00K20.00K
Investment in Securities-3.00M-1.00M6.00M-6.00M
Investing Cash Flow-2.93M-982.00K-13.00K5.99M-6.01M-50.00K
Issuance of Common Stock12.67M4.01M10.10M5.55M7.93M
Other Financing Activities-270.00K-190.00K-1.24M-932.00K-446.00K
Financing Cash Flow12.40M3.82M8.86M4.62M7.48M
Foreign Exchange Rate Adjustments-1.00K-2.00K6.00K2.00K
Net Cash Flow5.06M-1.12M-3.77M3.93M-12.46M881.00K
Free Cash Flow-4.41M-3.96M-12.63M-6.69M-6.46M-6.60M
Free Cash Flow Margin-14,229.03%-23,276.47%
Free Cash Flow Per Share-4.14-6.11-91.38-87.99-233.31
Levered Free Cash Flow-2.19M-2.00M-7.21M-3.56M-3.12M-3.90M
Unlevered Free Cash Flow-2.19M-2.00M-7.21M-3.56M-3.12M-3.90M
Change in Working Capital-271.00K-152.00K1.66M1.63M672.00K-538.00K

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization2.55M2.51M2.94M4.29M4.39M13.94M
Enterprise Value-8.93M-910.13K211.16K-4.20M-8.57M-4.40M
Last Close Price0.733.2116.77330.00495.241,596.00
PS Ratio82.41147.82
PB Ratio0.140.271.610.590.400.77
P/TBV Ratio0.292.641.610.590.400.77
Debt / Equity Ratio0.000.000.030.01
Net Debt / Equity Ratio-0.70-0.44-2.31-1.10-0.92-0.92
Net Debt / EBITDA Ratio2.710.950.290.831.152.30
Net Debt / FCF Ratio2.601.040.331.191.572.50
Asset Turnover0.000.00
Quick Ratio5.001.751.793.359.6222.13
Current Ratio5.071.781.814.0711.5425.12
Return on Equity (ROE)-45.33%-90.37%-321.92%-102.34%-60.42%-41.76%
Return on Assets (ROA)-21.88%-38.75%-126.89%-53.82%-35.30%-24.43%
Return on Capital Employed (ROCE)-31.60%-53.60%-704.40%-127.40%-78.70%-39.40%
Earnings Yield-684.31%-192.53%-497.01%-218.04%-200.35%-51.98%
FCF Yield-172.66%-157.47%-430.44%-156.07%-147.32%-47.36%
Buyback Yield / Dilution-229.04%-368.68%-81.90%-174.29%